Adult disseminated primary papular xanthoma treated with doxycycline [9]

Archives of Dermatology

Volumn 143, Issue 5, 2007, Pages 667-669

  Bastida, Jesús ^a   Camacho Galán, Rafael ^b   Armesto Fernández, M Aser ^b   Díaz Cascajo, Carlos ^b  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DOXYCYCLINE; ISOTRETINOIN;

ADULT; CASE REPORT; CELL CULTURE; FEMALE; HISTIOCYTE; HUMAN; LETTER; MAST CELL; PRIMARY PAPULAR XANTHOMA; PRIORITY JOURNAL; SKIN DEFECT; ULTRASTRUCTURE; UPREGULATION; XANTHOMA;

ADULT; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS;

EID: 34248995208     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.5.667     Document Type: Letter

References (11)

1. Hu CH, Winkelmann RK. Unusual normolipidemic cutaneous xanthomatosis: a comparison of two cases illustrating the differential diagnosis. Acta Derm Venereol. 1977;57:421-429.
2. Beurey J, Lamaze M, Weber M, Delrous JL, Kremer B, Chaulieu Y. Xanthoma disseminatum (syndrome de Montgomery). Ann Dermatol Venereol. 1979;106:353-359.
3. Thomas RH, Miller NE, Payne CME, Black MM. Papular xanthoma associated with primary dysbetalipoproteinaemia. J R Soc Med. 1982;75:906-908.
4. Sanchez RL, Raimer SS, Peltier F, Swedo J. Papular xanthoma: a clinical, histologic and ultrastructural study. Arch Dermatol. 1985;121:626-631.
5. Bundino S, Zina AM, Aloi F. Papular xanthoma: clinical, histological and ultrastructural study. Dermatologica. 1988;177:382-385.
6. Pfennigsdorf S, Lieb WE. Papulöse Xanthome der lider. Klin Monatsbl Augenheilkd. 1997;210:113-115.
7. Caputo R, Passoni E, Cavicchini S. Papular xanthoma associated with angiokeratoma of Fordyce: considerations on the nosography of this rare non-Langerhans cell histiocytomatosis. Dermatology. 2003;206:165-168.
8. Breier F, Zelger B, Reiter H, Gschnait F, Zelger BWH. Papular xanthoma: a clinicopathological study of 10 cases. J Cutan Pathol. 2002;29:200-206.
9. Weinberg JM. The anti-inflammatory effects of tetracyclines. Cutis. 2005;75(4) (suppl):6-11.
10. Sandler C, Nurmi K, Lindstedt KA, et al. Chemically modified tetracyclines induce apoptosis in cultured mast cells. Int Immunopharmacol. 2005;5:1611-1621.
11. Chu AC. Histiocytoses. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. Vol 3. Malden, Mass: Blackwell Publishing; 2004:52.1-52.23.